Pulvinal Beclometasone and Pulvinal Salbutamol dry powder inhalers have been discontinued following a decline in demand.
Stocks of Pulvinal Beclometasone 100, 200 and 400 microgram are expected to run out by the end of 2015. A limited supply of Pulvinal Salbutamol will be available until the middle of January 2016.
Healthcare professionals should identify patients currently using these devices and discuss alternatives as soon as possible.
For a guide to available inhalers for the treatment of asthma and COPD, see the asthma and COPD preparations and compatible devices table and the guide to breath-actuated inhalers.